Literature DB >> 33886690

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.

Manon Laporte1, Valerie Raeymaekers1, Ria Van Berwaer1, Julie Vandeput1, Isabel Marchand-Casas1, Hendrik-Jan Thibaut1,2, Dominique Van Looveren1,2, Katleen Martens3, Markus Hoffmann4,5, Piet Maes6, Stefan Pöhlmann4,5, Lieve Naesens1, Annelies Stevaert1.   

Abstract

The high transmissibility of SARS-CoV-2 is related to abundant replication in the upper airways, which is not observed for the other highly pathogenic coronaviruses SARS-CoV and MERS-CoV. We here reveal features of the coronavirus spike (S) protein, which optimize the virus towards the human respiratory tract. First, the S proteins exhibit an intrinsic temperature preference, corresponding with the temperature of the upper or lower airways. Pseudoviruses bearing the SARS-CoV-2 spike (SARS-2-S) were more infectious when produced at 33°C instead of 37°C, a property shared with the S protein of HCoV-229E, a common cold coronavirus. In contrast, the S proteins of SARS-CoV and MERS-CoV favored 37°C, in accordance with virus preference for the lower airways. Next, SARS-2-S-driven entry was efficiently activated by not only TMPRSS2, but also the TMPRSS13 protease, thus broadening the cell tropism of SARS-CoV-2. Both proteases proved relevant in the context of authentic virus replication. TMPRSS13 appeared an effective spike activator for the virulent coronaviruses but not the low pathogenic HCoV-229E virus. Activation of SARS-2-S by these surface proteases requires processing of the S1/S2 cleavage loop, in which both the furin recognition motif and extended loop length proved critical. Conversely, entry of loop deletion mutants is significantly increased in cathepsin-rich cells. Finally, we demonstrate that the D614G mutation increases SARS-CoV-2 stability, particularly at 37°C, and, enhances its use of the cathepsin L pathway. This indicates a link between S protein stability and usage of this alternative route for virus entry. Since these spike properties may promote virus spread, they potentially explain why the spike-G614 variant has replaced the early D614 variant to become globally predominant. Collectively, our findings reveal adaptive mechanisms whereby the coronavirus spike protein is adjusted to match the temperature and protease conditions of the airways, to enhance virus transmission and pathology.

Entities:  

Year:  2021        PMID: 33886690     DOI: 10.1371/journal.ppat.1009500

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  41 in total

Review 1.  Cellular host factors for SARS-CoV-2 infection.

Authors:  Jim Baggen; Els Vanstreels; Sander Jansen; Dirk Daelemans
Journal:  Nat Microbiol       Date:  2021-09-01       Impact factor: 17.745

Review 2.  Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.

Authors:  Ranjan Ramasamy
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

3.  Body temperature variation controls pre-mRNA processing and transcription of antiviral genes and SARS-CoV-2 replication.

Authors:  Bruna Los; Marco Preußner; Kathrin Eschke; Ricardo Martin Vidal; Azza Abdelgawad; Didrik Olofsson; Sandra Keiper; Margarida Paulo-Pedro; Alica Grindel; Stefan Meinke; Jakob Trimpert; Florian Heyd
Journal:  Nucleic Acids Res       Date:  2022-06-17       Impact factor: 19.160

4.  Possible effects of air temperature on COVID-19 disease severity and transmission rates.

Authors:  Dominique Kang; Clifford Ellgen; Erik Kulstad
Journal:  J Med Virol       Date:  2021-05-03       Impact factor: 20.693

5.  Should we discount the laboratory origin of COVID-19?

Authors:  Rossana Segreto; Yuri Deigin; Kevin McCairn; Alejandro Sousa; Dan Sirotkin; Karl Sirotkin; Jonathan J Couey; Adrian Jones; Daoyu Zhang
Journal:  Environ Chem Lett       Date:  2021-03-25       Impact factor: 13.615

6.  Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union.

Authors:  Suzy Huijghebaert; Guido Vanham; Myriam Van Winckel; Karel Allegaert
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

Review 7.  A Review on Expression, Pathological Roles, and Inhibition of TMPRSS2, the Serine Protease Responsible for SARS-CoV-2 Spike Protein Activation.

Authors:  Jyotirmoy Sarker; Pritha Das; Sabarni Sarker; Apurba Kumar Roy; A Z M Ruhul Momen
Journal:  Scientifica (Cairo)       Date:  2021-07-24

8.  Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells.

Authors:  Gabriel Augusto Pires de Souza; Marion Le Bideau; Celine Boschi; Lorène Ferreira; Nathalie Wurtz; Christian Devaux; Philippe Colson; Bernard La Scola
Journal:  Viruses       Date:  2021-12-23       Impact factor: 5.048

9.  Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide.

Authors:  Nathalie Vanderheijden; Annelies Stevaert; Jiexiong Xie; Xiaolei Ren; Cyril Barbezange; Sam Noppen; Isabelle Desombere; Bruno Verhasselt; Peter Geldhof; Nick Vereecke; Veerle Stroobants; Dayoung Oh; Merijn Vanhee; Lieve M J Naesens; Hans J Nauwynck
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

Review 10.  Proteases and variants: context matters for SARS-CoV-2 entry assays.

Authors:  Christian S Stevens; Kasopefoluwa Y Oguntuyo; Benhur Lee
Journal:  Curr Opin Virol       Date:  2021-07-24       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.